HELP     Sign In
Search

Relevance to Autism

Genetic association has been found between the GABRB1 gene and autism. Positive associations were found in particular through interaction with GABRA4 (Ma et al., 2005) and in families with a positive history of seizures (Collins et al., 2006).

Molecular Function

The encoded protein is a subunit of the GABA-A receptor. Neurotransmission is predominantly mediated by a gated chloride channel activity intrinsic to the receptor.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.
ASD
Positive Association
De novo mutations in epileptic encephalopathies.
Epilepsy
IS, LGS, DD, ID, ASD, ADHD
Positive Association
Investigation of autism and GABA receptor subunit genes in multiple ethnic groups.
ASD
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Support
ASD
DD, ID
Support
Integrating de novo and inherited variants in 42
ASD
Support
Integrative Analyses of De Novo Mutations Provide Deeper Biological Insights into Autism Spectrum Disorder.
ASD
Highly Cited
The rat beta 1-subunit of the GABAA receptor forms a picrotoxin-sensitive anion channel open in the absence of GABA.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN100R001 
 missense_variant 
 c.737T>C 
 p.Phe246Ser 
 De novo 
  
  
 GEN100R002 
 frameshift_variant 
 140+AT(delAT) 
 47-! 
 De novo 
  
  
 GEN100R003 
 missense_variant 
 c.733T>C 
 p.Tyr245His 
 De novo 
  
 Simplex 
 GEN100R004 
 missense_variant 
 c.566T>C 
 p.Ile189Thr 
 De novo 
  
  
 GEN100R005 
 missense_variant 
 c.686C>T 
 p.Ala229Val 
 De novo 
  
  
 GEN100R006 
 missense_variant 
 c.1365G>A 
 p.Met455Ile 
 Unknown 
  
 Simplex 

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN100C001 
 intron_variant 
 rs2351299 
 c.241-19901G>T 
 N/A 
 ASD cases with positive history for seizures 
 Discovery 
 GEN100C002 
 synonymous_variant 
 rs4482737 
 c.508C=;c.508C>T;c.508T>C 
 c.508T>C 
 ASD cases with positive history for seizures 
 Discovery 
 GEN100C003 
 3_prime_UTR_variant 
 rs3832300 
 c.*300_*301insT 
 N/A 
 ASD cases with positive history for seizures 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
4
Duplication
 3
 
4
Duplication
 1
 
4
Duplication
 1
 
4
Duplication
 1
 
4
Duplication
 1
 

Model Summary

Altered GABAergic inhibitory transmission has been implicated in autism, with mutations in GABA-A receptors having been identified as genetic underpinnings to the disease. The Gabrb1 mutant model provides further evidence of this, exhibiting alterations in behavior. Specifically, mutant mice display decreased social interaction and increased grooming, with no change in general locomotor activity or anxiety. The model also shows upregulated NMDARs and NMDAR-currents, with increased levels of GluN1 and GluN2B in the hippocampus. Additionally, Gabrb1 mutant mice exhibit increased learning, displaying heightened responses to fear conditioning as well as enhanced susceptibility to picrotoxin-induced seizures. Alterations in social interaction, grooming, learning, and seizure susceptibility were all rescued by treatment with the NMDAR antagonist memantine or the glutamine synthetase antagonist methionine sulfoximine.

References

Type
Title
Author, Year

M_GABRB1_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Gabrb1 knockout C57BL/6J mice were generated by TALEN (transcription activator-like effector nuclease). Exon 1 of the mouse Gabrb1 gene (chr5: 71857359-72294152, NCBI Reference Sequence: NC_000071.7) was chosen as the TALEN target site. TALEN mRNAs were generated by in vitro transcription and then injected into fertilized eggs.
Allele Type: Knockout
Strain of Origin: Not specified
Genetic Background: C57BL/6J
ES Cell Line: Not specified
Mutant ES Cell Line:
Model Source: Cyagen Biosciences Inc.

M_GABRB1_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Neuroreceptor levels: glutamate receptors: nmda receptors1
Increased
Description: Gabrb1 mutant mice exhibited upregulation of the NMDAR proteins GluN1 and GluN2B in the hippocampus.
Exp Paradigm: hippocampus
 Western blot
 8â??10 weeks
Synaptic transmission: excitatory1
Increased
Description: NMDAR-currents were increased in hippocampal CA1 neurons in Gabrb1 mutant mice compared to wildtype controls, while the AMPAR-currents were unchanged.
Exp Paradigm: CA1 neurons
 Whole-cell patch clamp
 3â??4 weeks
Synaptic transmission: inhibitory1
Decreased
Description: GABAAR-currents were reduced in hippocampal CA1 neurons in Gabrb1 mutant mice compared to wildtype controls.
Exp Paradigm: CA1 neurons
 Whole-cell patch clamp
 3â??4 weeks
Self grooming1
Increased
Description: Gabrb1 mutant mice displayed longer total duration time in repetitive self-grooming compared to wildtype controls.
 Grooming behavior assessments
 8â??12 weeks
Seizures1
Increased
Description: 8 of 12 Gabrb1 mutant male mice (66.67%) and 3 of 14 wildtype male mice (21.43%) died after picrotoxin injection, showing significantly higher severity of symptoms in Gabrb1 mutant mice. However, no difference in lethality was observed between the mutant and wildtype female mice.
Exp Paradigm: Picrotoxin administration
 Survival analysis
 8â??12 weeks
Seizures1
Increased
Description: After picrotoxin 5 mg/kg administration, Gabrb1 mutant mice exhibited increased seizure duration of generalized convulsions (in minutes) compared to wildtype controls. Additionally, Gabrb1 mutant mice displayed similar latency to seizure onset compared to wildtype controls.
Exp Paradigm: Picrotoxin administration
 Observation of chemically induced seizures
 8â??12 weeks
Social interaction1
Decreased
Description: In the home cage social interaction test, Gabrb1 mutant mice spent less time engaged in exploring a stranger mouse, an active social interaction, compared to wildtype controls.
 Home cage behavior
 8â??12 weeks
Social approach1
Decreased
Description: Gabrb1 mutant mice showed less preference for sniffing the stranger 2 mouse rather than the familiar stranger 1 mouse, with no difference in the time spent in either chamber. This was further exhibited by a decreased Preference Index.
Exp Paradigm: novel mouse (stranger 2) vs. familiar mouse (stranger 1)
 Three-chamber social approach test
 8â??12 weeks
Spatial learning1
Increased
Description: During the training trials, Gabrb1 mutant and wildtype control mice showed significant improvement in escape latency time to find the hidden platform, with Gabrb1 performing significantly faster than the wildtype mice. Further, the swimming velocity for the Gabrb1 mutant mice was not different compared with wildtype controls.
 Morris water maze test
 8â??12 weeks
Cued or contextual fear conditioning1
Increased
Description: Gabrb1 mutant mice showed increased fear memory compared to wildtype controls in the test phase of the fear conditioning test, with a significantly higher percentage of freezing time.
Exp Paradigm: 24 hours after fear conditioning
 Fear conditioning test
 8â??12 weeks
Spatial reference memory1
Increased
Description: Gabrb1 mutant mice exhibited a higher number of platform crossings when the platform was taken away compared to wildtype controls.
 Morris water maze test
 8â??12 weeks
Differential gene expression1
Abnormal
Description: Immunostaining of hippocampal slices for GS (encoding by Glul) and SLC38A3 in astrocytes, showed significant upregulation of GS and SLC38A3 in CA1 GFAP+ astrocytes of Gabrb1 mutant mice compared to wildtype controls.
Exp Paradigm: CA1 neurons
 Immunohistochemistry
 6 weeks
Protein localization: synapse1
Increased
Description: GluN1 and GluN2B were upregulated in both the extrasynaptic and synaptic fractions of Gabrb1 mutant mouse hippocampi.
Exp Paradigm: hippocampus
 Fractionation
 8â??10 weeks
Differential gene expression1
Abnormal
Description: Immunoprecipitation of the endogenous SHANK3 protein confirmed SHANK3-GluN1 and SHANK3-GluN2B interactions in the mouse hippocampus.
Exp Paradigm: hippocampus
 Immunoprecipitation
 8â??10 weeks
Protein localization: synapse1
Increased
Description: Gabrb1 mutant mice exhibited GluN2B upregulation in the PSD95 position compared to wildtype controls.
Exp Paradigm: hippocampus
 Immunohistochemistry
 8â??10 weeks
Differential gene expression1
Abnormal
Description: Gabrb1 mutant mice exhibited upregulation of Grin1/ 2b/2d, Gria1, Grik1/3/4, and Slc17a7.
Exp Paradigm: hippocampus
 Quantitative PCR (qRT-PCR)
 8â??10 weeks
Targeted expression1
Decreased
Description: Gabrb1 mutant mice exhibited significantly decreased mRNA expression levels of the Gabrb1 gene in the hippocampus compared to wildtype controls.
Exp Paradigm: hippocampus
 Quantitative PCR (qRT-PCR)
 not specified
Differential gene expression1
Abnormal
Description: The samples of Gabrb1 knockout mice were well separated from those of wildtype mice in principal component analysis (PCA) by 86% variance, suggesting a consistent transcriptomic difference between the knockout mice and WT mice. Out of 16,403 expressed genes in the brain, 1,587 were identified as differentially expressed genes, including 916 upregulated genes and 671 down-regulated genes.
 RNA sequencing
 8â??10 weeks
Targeted expression1
Decreased
Description: Gabrb1 mutant mice exhibited significantly decreased Gabrb1 levels in the hippocampus compared to wildtype controls.
Exp Paradigm: hippocampus
 Western blot
 not specified
Size/growth1
 No change
 Body weight measurement
 4, 8, 12 weeks
Anxiety1
 No change
 Elevated plus maze test
 8â??12 weeks
General locomotor activity1
 No change
 Open field test
 8â??12 weeks
Brain size1
 No change
 Measurement of tissue weight
 12 weeks
Membrane potential1
 No change
 Whole-cell patch clamp
 3â??4 weeks
Presynaptic function: paired-pulse facilitation1
 No change
 Whole-cell patch clamp
 3â??4 weeks
Social approach1
 No change
 Three-chamber social approach test
 8â??12 weeks
 Not Reported:


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
AKAP5 A kinase (PRKA) anchor protein 5 9495 P24588 GST
Brandon NJ , et al. 2003
GNB2L1 guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 10399 P63244 GST; Overlay binding assay
Brandon NJ , et al. 1999
PRKACA protein kinase, cAMP-dependent, catalytic, alpha 282322 P00517 in vitro kinase assay
Moss SJ , et al. 1992
PRKCB protein kinase C, beta 25023 P68403 in vitro kinase assay; GST; Overlay binding assay
Brandon NJ , et al. 1999
ARFGEF2 ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) 296380 Q7TSU1 Y2H
Charych EI , et al. 2004
C1QBP complement component 1, q subcomponent binding protein 29681 O35796 Y2H
Schaerer MT , et al. 2001

HELP
Copyright © 2017 MindSpec, Inc.